Stay updated on Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.
Latest updates to the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page
- Check6 days agoChange DetectedThe type of intervention has been updated from version v2.13.3 to v2.14.0.SummaryDifference1.0%
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe study 'Venetoclax in Combination with 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy (VENAZA-5S)' has been updated to a new version (v2.13.3) on 2024-12-09, replacing the previous version (v2.13.2) from 2023-08-08.SummaryDifference2%
- Check42 days agoChange DetectedThe website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check57 days agoChange DetectedNo new additions were noted, but a significant section of content related to data download options and study details has been removed.SummaryDifference14%
- Check71 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new download options in various file formats and a comprehensive selection of data fields for studies.SummaryDifference16%
- Check79 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax Combo with Azacitidine in Untreated AML Clinical Trial page.